Skip to content
by Legal Desire
SIGN IN GO PRO
19 June 2024

Latham & Watkins Advises Boston Scientific in US$1.16 Billion Acquisition of Silk Road Medical

M&A Healthcare & Life Sciences Signed United States

Advising firms

Latham & Watkins LLP
Buy-side acting for Boston Scientific Corporation

Deal team

21 lawyers named
LawyerFirmSeniorityPracticeOffice
Julie Scallen Lead Latham & Watkins LLP Partner M&A Boston
Ian Nussbaum Lead Latham & Watkins LLP Partner M&A New York
Shannon Cheng Latham & Watkins LLP Associate M&A Not stated
Kennedy Holmes Latham & Watkins LLP Associate M&A Not stated
Amy Lutfi Latham & Watkins LLP Associate M&A Not stated
Rose Kenyon Latham & Watkins LLP Associate M&A Not stated
Ivana Valdez Latham & Watkins LLP Associate M&A Not stated
Ashley Campfield Latham & Watkins LLP Associate M&A Not stated
Oliver Mobasser Latham & Watkins LLP Associate intellectual property and licensing Not stated
Josh Friedman Latham & Watkins LLP Partner benefits and compensation Boston
Rebecca Fishbein Latham & Watkins LLP Associate benefits and compensation Not stated
Tessa Young Latham & Watkins LLP Associate benefits and compensation Not stated
Nicholas DeNovio Latham & Watkins LLP Partner tax Washington, D.C.
Abigail Friedman Latham & Watkins LLP Associate tax Not stated
Nolon Blaylock Latham & Watkins LLP Associate tax Not stated
Betty Pang Latham & Watkins LLP Partner life sciences regulatory Bay Area
Elizabeth Richards Latham & Watkins LLP Partner life sciences regulatory Washington, D.C.
Leia Gu Latham & Watkins LLP Associate life sciences regulatory Not stated
Evan Miller Latham & Watkins LLP Associate life sciences regulatory Not stated
Heather Deixler Latham & Watkins LLP Partner data privacy Bay Area
Mitch Bennett Latham & Watkins LLP Associate data privacy Not stated

Stated terms

Stated value
USD 1.16bn (US$1.16 billion)
What the figure measures
Enterprise value
Client
Boston Scientific CorporationBuy-side
Counterparties
Silk Road Medical, Inc. (Sell-side)